Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study
    Journal Article

    Blinder, V. S.; Patil, S.; Thind, A.; Diamant, A.; Hudis, C. A.; Basch, E.; Maly, R. C.
    Cancer (2012)

    Fulltext@MSK | Save
  • Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy
    Journal Article

    Waitz, R.; Solomon, S. B.; Petre, E. N.; Trumble, A. E.; FassoĢ€, M.; Norton, L.; Allison, J. P.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer
    Journal Article

    Stadler, Z. K.; Salo-Mullen, E.; Patil, S. M.; Pietanza, M. C.; Vijai, J.; Saloustros, E.; Hansen, N. A. L.; Kauff, N. D.; Kurtz, R. C.; Kelsen, D. P.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Randomised trial of expressive writing for distressed metastatic breast cancer patients
    Journal Article

    Mosher, C. E.; Duhamel, K. N.; Lam, J.; Dickler, M.; Li, Y.; Massie, M. J.; Norton, L.
    Psychology & Health (2012)

    Fulltext@MSK | Save
  • A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: A trial coordinated by the Eastern Cooperative Oncology Group
    Journal Article

    Miller, K. D.; O'neill, A.; Perez, E. A.; Seidman, A. D.; Sledge, G. W.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA)
    Journal Article

    Mavaddat, N.; Barrowdale, D.; Andrulis, I. L.; Domchek, S. M.; Eccles, D.; Nevanlinna, H.; Ramus, S. J.; Spurdle, A.; Robson, M.; Sherman, M.; more...
    Cancer Epidemiology Biomarkers and Prevention (2012)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Induction of cutaneous squamous cell carcinomas by RAF inhibitors: Cause for concern?
    Journal Article

    Lacouture, M. E.; O'reilly, K.; Rosen, N.; Solit, D. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
    Journal Article

    Gajria, D.; Gonzalez, J.; Feigin, K.; Patil, S.; Chen, C.; Theodoulou, M.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; more...
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • The paradox of triple negative breast cancer: Novel approaches to treatment
    Journal Article

    Fornier, M.; Fumoleau, P.
    Breast Journal (2012)

    Fulltext@MSK | Save